Impact of Exercise on the Course of Dermatomyositis: A Narrative Review of Recent Studies
DOI:
https://doi.org/10.12775/QS.2024.31.55447Keywords
dermatomyositis, physical activity, exercise, muscle weakness, idiopathic inflammatory myopathiesAbstract
Introduction and Purpose: Dermatomyositis (DM) is a rare autoimmune inflammatory myopathy characterized by muscle weakness and distinctive skin manifestations, impacting both children and adults. This narrative review aims to examine the latest studies assessing the impact of physical activity on the course of dermatomyositis and determine which forms of exercise are beneficial for DM patients.
Methods: A comprehensive literature review was conducted using the PubMed and Google Scholar databases, focusing on articles published between 2018 and 2024.
State of Knowledge: The review identified consistent evidence supporting the safety and efficacy of exercise in DM patients. Exercise regimens, including resistance, aerobic, and stretching exercises, were found to improve muscle strength, aerobic capacity, and metabolic functions without increasing disease activity. Novel exercise approaches, such as blood flow restriction training and aquatic plyometric exercises, also showed promising results. However, the heterogeneity of the trials and small sample sizes highlight the need for larger, more diverse cohorts and long-term studies
Summary: The findings underscore the potential of structured exercise programs to enhance muscle strength, aerobic capacity, and overall physical function in DM patients. These improvements are achieved without exacerbating disease activity, highlighting the safety of exercise interventions. The review emphasizes the importance of incorporating physical activity into treatment plans for DM, advocating for personalized exercise prescriptions tailored to the unique inflammatory nature of idiopathic inflammatory myopathies (IIM).
References
Di Ludovico A, Rinaldi M, Lauriola F, et al. The Diagnostic Role of Skin Manifestations in Rheumatic Diseases in Children: A Critical Review of Paediatric Vasculitis. Int J Mol Sci. 2024;25(13):7323. Published 2024 Jul 3. https://doi.org/10.3390/ijms25137323.
Khojah A, Pachman LM, Bukhari A, et al. Decreased Peripheral Blood Natural Killer Cell Count in Untreated Juvenile Dermatomyositis Is Associated with Muscle Weakness. Int J Mol Sci. 2024;25(13):7126. Published 2024 Jun 28. https://doi.org/10.3390/ijms25137126.
Huang T, Ding T, Ding L, et al. A new proposal for phenotypic classification and outcome assessment of dermatomyositis based on clinical manifestations and serological testing. An Bras Dermatol. 2024;99(3):342-349. https://doi.org/10.1016/j.abd.2023.06.005.
Kondoh Y, Bando M, Kawahito Y, Sato S, Suda T, Kuwana M. Identification and management of interstitial lung disease associated with systemic sclerosis (SSc-ILD), rheumatoid arthritis (RA-ILD), and polymyositis/dermatomyositis (PM/DM-ILD): development of expert consensus-based clinical algorithms. Expert Rev Respir Med. Published online July 15, 2024. https://doi.org/10.1080/17476348.2024.2374910.
Oyama M, Ohnuki Y, Uruha A, et al. Association Between HLA Alleles and Autoantibodies in Dermatomyositis Defined by Sarcoplasmic Expression of Myxovirus Resistance Protein A. J Rheumatol. 2023;50(9):1159-1164. https://doi.org/10.3899/jrheum.2022-1321.
Sherman MA, Yang Q, Gutierrez-Alamillo L, et al. Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti-Transcriptional Intermediary Factor 1γ Juvenile-Onset Dermatomyositis. Arthritis Rheumatol. 2024;76(4):631-637. https://doi.org/10.1002/art.42768.
Chen Y, Liu H, Luo Z, et al. ASM is a therapeutic target in dermatomyositis by regulating the differentiation of naive CD4 + T cells into Th17 and Treg subsets. Skelet Muscle. 2024;14(1):16. Published 2024 Jul 18. https://doi.org/10.1186/s13395-024-00347-1.
Sassetti C, Borrelli C, Mazuy M, Turrini I, Rigante D, Esposito S. The relationship between infectious agents and juvenile dermatomyositis: a narrative update from the pediatric perspective. Front Immunol. 2024;15:1377952. Published 2024 Apr 10. https://doi.org/10.3389/fimmu.2024.1377952.
Alexanderson H. Exercise in Myositis. Curr Treatm Opt Rheumatol. 2018;4(4):289-298. https://doi.org/10.1007/s40674-018-0113-3.
Ramdharry GM, Anderson M. Exercise in myositis: What is important, the prescription or the person?. Best Pract Res Clin Rheumatol. 2022;36(2):101772. https://doi.org/10.1016/j.berh.2022.101772.
Christopher-Stine L, Wan GJ, Kelly W, McGowan M, Bostic R, Reed ML. Patient-reported dermatomyositis and polymyositis flare symptoms are associated with disability, productivity loss, and health care resource use. J Manag Care Spec Pharm. 2020;26(11):1424-1433. https://doi.org/10.18553/jmcp.2020.26.11.1424.
Kleitsch J, Weiner JD, Pandya R, Concha JS, Lim D, Werth VP. The physical and emotional impact of cutaneous dermatomyositis: a qualitative study. Arch Dermatol Res. 2023;315(8):2431-2435. https://doi.org/10.1007/s00403-023-02625-2.
de Oliveira DS, Bruna Pires Borges I, Kazue Nagahashi Marie S, Marcondes Lerario A, Oba-Shinjo SM, Katsuyuki Shinjo S. Exercise training attenuates skeletal muscle fat infiltration and improves insulin pathway of patients with immune-mediated necrotizing myopathies and dermatomyositis. Arch Rheumatol. 2022;38(2):189-199. Published 2022 Oct 21. https://doi.org/10.46497/ArchRheumatol.2023.9257.
Calado D, Moeda F, Hatia M, Pinho S, Amaral-Silva M. Rehabilitation and Exercise in Dermatomyositis: A Case Report and Narrative Review of the Literature. Cureus. 2022;14(12):e33034. Published 2022 Dec 28. https://doi.org/10.7759/cureus.33034.
da Silva BISL, Dos Santos BRJ, Carneiro JA, Silva FMFE, de Souza JM. Physical exercise for dermatomyositis and polymyositis: a systematic review and meta-analysis. Clin Rheumatol. 2022;41(9):2635-2646. https://doi.org/10.1007/s10067-022-06281-1.
Samhan A, Mohamed N, Elnaggar R, Mahmoud W. Assessment of the Clinical Effects of Aquatic-based Exercises in the Treatment of Children With Juvenile Dermatomyositis: A 2x2 Controlled-Crossover Trial. Arch Rheumatol. 2019;35(1):97-106. Published 2019 Oct 17. https://doi.org/10.5606/ArchRheumatol.2020.7548.
Landon-Cardinal O, Bachasson D, Guillaume-Jugnot P, et al. Relationship between change in physical activity and in clinical status in patients with idiopathic inflammatory myopathy: A prospective cohort study. Semin Arthritis Rheum. 2020;50(5):1140-1149. https://doi.org/10.1016/j.semarthrit.2020.06.014.
Astley C, Sieczkowska SM, Marques IG, et al. Home-based exercise program for adolescents with juvenile dermatomyositis quarantined during COVID-19 pandemic: a mixed methods study. Pediatr Rheumatol Online J. 2021;19(1):159. Published 2021 Nov 13. https://doi.org/10.1186/s12969-021-00646-7.
Elnaggar RK, Abd El-Nabie WA. Efficacy of aqua-based plyometric exercises in the rehabilitation of patients with juvenile dermatomyositis: A randomized crossover pilot study. Int J Rheum Dis. 2021;24(7):930-940. https://doi.org/10.1111/1756-185X.14152.
Corrado B, Ciardi G, Lucignano L. Supervised Physical Therapy and Polymyositis/Dermatomyositis-A Systematic Review of the Literature. Neurol Int. 2020;12(3):77-88. Published 2020 Nov 24. https://doi.org/10.3390/neurolint12030015.
Waghe VR, Sasun AR, Raghumahanti R. Targeting Weakness With a Combination of Isotonic Exercises in Dermatomyositis With Polyneuropathy: A Case Report. Cureus. 2024;16(1):e52873. Published 2024 Jan 24. https://doi.org/10.7759/cureus.52873.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Katarzyna Chawrylak, Maria Kubas, Katarzyna Krzemińska, Julia Kuszneruk, Magdalena Kłusek

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 144
Number of citations: 0